Incidence Rates and Adjusted Hazard Ratios of Developing Hepatocellular Carcinoma (HCC) by Risk Predictors in 1,822 Anti-HCV-Seronegative Chronic HBV Carriers.

+: Using the quartile of each seromarker as the cut-off point except AAR.
*: Age, gender, and study townships were included in Cox proportional hazards models.
Abbreviation: HCC, hepatocellular carcinoma; HBeAg, hepatitis B e antigen; Anti-HCV, antibodies against hepatitis C virus; HBV, hepatitis B virus; AST, aspartate aminotransferase; ALT, alanine aminotransferase; AAR, AST/ALT ratio; AFP, alpha-fetoprotein; GGT, gamma-glutamyltransferase.